ArticleBreast cancer research and treatment2018

The combined presence of CD20 + B cells and PD-L1 + tumor-infiltrating lymphocytes in inflammatory breast cancer is prognostic of improved patient outcome.

H Arias-Pulido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.